Next Article in Journal
Determination of Chemical Oxygen Demand (COD) Using Nanoparticle-Modified Voltammetric Sensors and Electronic Tongue Principles
Previous Article in Journal
Development of an Integrated In-Vehicle Driver Breath Ethanol System Based on α-Fe2O3 Sensing Material
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Proceeding Paper

Developing an Electrochemical Biosensor for the Detection of Hemagglutinin Protein of Influenza A Virus Subtype H1N1 in Artificial Saliva †

by
Carlos Torres-Méndez
1,*,
Jayendra Ellamathy
1,
Maria Ines Mascarenhas
2,
Yifan Liu
1,
Georgia-Vasiliki Gkountana
2,*,
Patrizia Kühne
2,
Javier Sebastián
1,
Ivana Jovanovic
2,
David Bern
1,
Sharmilee Nandi
2,
Maike Lüftner
2,
Viktoria Langwallner
1,
Maria Lysandrou
2,
Sam Taylor
1,
Klara Martinovic
2,
Abdul-Raouf Atif
1,
Ehsan Manouchehri Doulabi
2,
Masood Kamali-Moghaddam
2,* and
Gemma Mestres
1,*
1
Division of Biomedical Engineering, Department of Materials Science and Engineering, Uppsala University, Box 35, 751 03 Uppsala, Sweden
2
Genetics and Pathology, Science for Life Laboratory, Department of Immunology, Uppsala University, 751 08 Uppsala, Sweden
*
Authors to whom correspondence should be addressed.
Presented at the 1st International Electronic Conference on Chemical Sensors and Analytical Chemistry, 1–15 July 2021; Available online: https://csac2021.sciforum.net/.
Chem. Proc. 2021, 5(1), 80; https://doi.org/10.3390/CSAC2021-10477
Published: 30 June 2021

Abstract

:
Influenza A virus belongs to the Orthomyxoviridae family and, to date, is one of the most important pathogens causing acute respiratory infections, such as the recent pandemic of 2009. Hemagglutinin (HA) is one of the surface proteins of the virus that allow it to interact with cellular molecules. Due to the fact that it is the most abundant protein in the virus capsule, it is the best target in the detection of the Influenza A H1N1 virus through biosensing devices. Our aim is to develop an electrochemical biosensor to detect H1 by modifying carbon screen-printed electrodes (CSPE) with gold nanoparticles and to add further functionalization with monoclonal antibodies that are specific to this protein. The electrodes were characterized by the means of cyclic voltammetry, differential pulse voltammetry and electrochemical impedance spectroscopy. Our preliminary results suggest that the selected monoclonal antibodies have acceptable affinity and bind effectively to the H1 protein and that the electrodes have a wide potential window in the presence of [Fe(CN)6]3−/4−. In the future, we will continue to develop this biosensor in hope that it will be commercialized and be common in medical procedures during flu seasons and future influenza pandemics.

1. Introduction

In 2009, a novel H1N1 influenza A virus caused a pandemic leading to the death of 151,700–575,400 people worldwide according to the estimates of the Centers for Disease Control and Prevention (CDC) of the United States [1,2]. H1N1 influenza is a subtype of influenza A virus that was previously detected in swine, which causes upper and, in some cases, lower respiratory tract infections in its host [1]. Influenza A virus causes one of the most common respiratory diseases globally, seasonal flu, and together with Influenza B, C, and D, is a part of the Orthomyxoviridae virus family. Moreover, influenza A virus belongs to the single-stranded RNA viruses. It has a segmented genome that encodes several viral proteins that are important for the pathogenesis of the virus [3,4]. Two of these proteins are important for detecting the virus in human specimens; these are hemagglutinin (HA) and neuraminidase (NA), which are the surface proteins of the virus involved in host invasion [5]. HA is the major protein of H1N1 and it is the protein with which the virus binds to the host’s cells and invades them, while NA helps in the viral spreading from cell to cell [5].
So far, most of the detection methods for the influenza A virus are characterized by a long detection time, expensive instruments and reagents, and the need for trained technicians, thus creating an inconvenience for both the patients and the healthcare workers [1,6]. The development of sensitive and rapid detection methods, such as biosensors, is now the focus of many research groups and could be a great solution to the aforementioned problem. A lot of different biorecognition elements can be used for the detection of an analyte. However, antibodies seem to be the most widely used type among these elements.
Antibodies are specialized, Y-shaped proteins that identify pathogens by selectively binding to their membranes [7]. Due to their high specificity and sensitivity, antibodies are ideal biorecognition elements for biosensors [8]. Other biorecognition elements commonly used in biosensors include enzymes, nucleic acids, aptamers and molecular-imprinted polymers [9]. The focus of this paper is the development of an electrochemical antibody-based biosensor for the detection of the influenza A surface protein H1.

2. Materials and Methods

2.1. Reagents and Materials

HA H1N1 protein, mouse monoclonal antibodies (mAbs) and rabbit polyclonal antibodies (pAb) were purchased from Sinobiological (Frankfurt, Germany). Secondary goat anti-Rabbit IgG antibodies (Alexa Fluor 568) were purchased from Thermo Fisher (Waltham, MA, USA). Chloroauric acid (HAuCl4), Sulphuric acid (H2SO4), 4 aminothiophenol (4-ATP), ethanol, potassium hexacyanoferrate (II) trihydrate and Potassium hexacyanoferrate (III) were purchased from Sigma Aldrich (Darmstadt, Germany). Carbon screen-printed electrodes (CSPE) were provided by Zimmer & Peacock (Horten, Norway).

2.2. Electrochemical Measurements

The EmStat Pico Module potentiostat controlled using the PSTrace 5.8 computer software was employed for all cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), chronoamperometric electrodeposition and differential pulse voltammetry (DPV) experiments. The CSPE was used as a three-electrode cell system comprising a carbon working electrode (WE), a carbon counter electrode (CE) and an Ag/AgCl reference electrode (RE). EIS measurements were made at 6 mV ac amplitude in the frequency range of 5.0 mHz to 50 kHz and the equivalent circuit models were fitted using PSTrace software.

2.3. Electrodeposition of Gold Nanoparticles on CSPE

A modified method from the literature was employed [10], an aqueous solution containing 2 mM HAuCl4 and 0.5 M H2SO4 was used to cover the CSPE, a chronoamperometric method using a constant potential of −0.25 V for 60 s was used to deposit gold nanoparticles on top of the CSPE, and the electrode was washed with abundant deionized water, left to dry at room temperature and identified as AuNP-CSPE.

2.4. Modification of AuNP-CSPE Electrodes with 4-ATP

A previously reported method was adapted [11], in a typical experiment, and the working electrode was covered with 10 µL of 10 mM 4-ATP solution in ethanol at room temperature (22 °C) for 15 min. Nonspecifically adsorbed molecules were flushed off by careful rinsing with ethanol and deionized water. The electrode was dried under a stream of nitrogen and identified as NH2-AuNP-CSPE. The amine functionality in the electrode could be used later to form an amide bond [12] and immobilize the mouse monoclonal antibodies against the HA H1N1 protein.

2.5. Testing of mAb Specificity and Sensitivity

The enzyme-linked immunosorbent assay (ELISA) was used for this purpose. The protocol used for this indirect sandwich ELISA assay was in accordance with the mAb provider [13].

3. Results and Discussion

3.1. Electrodeposition of Gold Nanoparticles

The CSPEs offered a reasonable potential window to study the redox reaction of the [Fe(CN)6]3−/4− system and showed a symmetric shape, and the distance between the oxidation and the reduction peaks was of 727 mV (Figure 1); this value was much higher than the prediction of the Nerst equation for single electron transfer reactions and was attributed to a drop in potential due to the resistance of the carbon material [14]. When the CSPEs were modified with gold nanoparticles, the reversibility of the [Fe(CN)6]3−/4− redox system increased as the distance between the oxidation and reduction peaks was 280 mV on the voltammogram; this was attributed to the increase in the surface area of the electrode and to the high conductivity of metallic gold nanoparticles.

3.2. Electrodeposition Length

Further study into the gold electrodeposition process as a function of time (Figure 2) showed that longer reaction times than one minute do not increase either the current response of the electrode or the reversibility of the system.

3.3. Characterization of NH2-AuNP-CSPE

The cyclic voltammogram of NH2-AuNP-CSPE showed promising results due to the functionalization of the nanoparticles with the 4-ATP linker molecule (Figure 1), as the reversibility of the system increased and the electron transfer process for the reduction and oxidation reactions of [Fe(CN)6]3−/4− was facilitated on these modified electrodes due to the π delocalized system of the linker molecule. The electrochemical impedance spectroscopy tests indicated a decrease in impedance after the modification of the electrodes with gold nanoparticles and 4-ATP linker (Figure 3). The Nyquist plot of the bare CSPE can be fitted to an equivalent circuit for a simple electron-transfer reaction and NH2-AuNP-CSPE can be fitted to the classical Randles equivalent circuit comprising the ohmic resistance of the electrolyte solution (RΩ) and the charge transfer resistance (RCT), in series with the Warburg impedance element (diffusion controlled impedance) and in parallel with a double layer capacitance (CDL) (Figure 4). The modified NH2-AuNP-CSPE showed a significantly smaller RCT and is, therefore, highly conductive compared to the bare CSPE.

3.4. Effect of the [Fe(CN)6]3−/4− Concentration

The effect of the [Fe(CN)6]3−/4− concentration over the current response was evaluated by the means of CV and DPV (Figure 5), with a higher concentration of the electroactive species in the solution implying that more [Fe(CN)6]3−/4 molecules could reach the surface of the NH2-AuNP-CSPE to undergo oxidation and reduction, respectively. In the experiment, higher current responses were observed at high concentrations of [Fe(CN)6]3−/4. This experiment provided a visual basis for the expected effect on the final design of the biosensor, where the NH2-AuNP-CSPE is going to be coupled to monoclonal antibodies against the H1 protein and a blocking effect over [Fe(CN)6]3−/4 (lowering the current response) could take place once the H1 protein is bound to the antibody-modified electrode.

3.5. mAb Characterization

To characterize the specificity of the monoclonal antibody targeting the H1 protein, an indirect sandwich ELISA was conducted. It was shown that the antibody can detect the H1 protein specifically (Figure 6). The approach was tested for different H1 concentrations and the lowest detectable concentration was 10 ng/mL.

4. Conclusions

Cost-effective CSPE were modified with gold nanoparticles and 4-ATP, and the electrodes were characterized by means of electrochemical methods in the presence of [Fe(CN)6]3−/4− complexes. The redox system [Fe(CN)6]3−/4− was found to be more reversible in the modified electrodes AuNP-CSPE and NH2-AuNP-CSPE than in the bare CSPE. The modified NH2-AuNP-CSPE showed a decrease in impedance compared to CSPE, indicating that the electron transfer process is more favorable in the modified electrode. With the indirect sandwich ELISA, it was shown that the monoclonal antibody specifically targets the HA H1N1 protein and can be further used in the biosensor setup. The amine functionality on the modified electrodes can be exploited to couple mouse monoclonal antibodies against the HA H1N1 protein in future work within this project. In addition to this, aims for future work include the detection of the HA H1N1 protein in artificial saliva using DPV, the establishment of a protocol using bovine serum albumin (BSA) to avoid non-specific binding, and the determination of the sensibility and detection limits of the biosensor.

Author Contributions

Conceptualization, data curation, formal analysis and visualization, C.T.-M., S.N., P.K., J.S. and V.L.; methodology, A.-R.A. and E.M.D.; software and validation, J.E., Y.L. and S.T.; investigation, I.J., M.L. (Maike Lüftner), K.M. and M.L. (Maria Lysandrou); resources, D.B.; writing—original draft preparation, C.T.-M., G.-V.G., P.K. and M.I.M.; writing—review and editing, C.T.-M. and P.K.; supervision, project administration and funding acquisition M.K.-M. and G.M. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the Disciplinary Domain of Medical and Pharmacy and Disciplinary Domain of Science and Technology at Uppsala University, Swedish Research Council under grant 2020-02258 and Swedish Institute’s scholarship to C. Torres-Méndez.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data are included herein and no data deposited in external repositories.

Acknowledgments

We are grateful to SensUs organization for all the support. We are also grateful to Quentin Palomar-Marchand for the technical advice provided for the electrochemical measurements and Zimmer & Peacock for providing the carbon screen-printed electrodes used in this study.

Conflicts of Interest

The authors declare no competing interest.

References

  1. Patel, M.; Dennis, A.; Flutter, C.; Khan, Z. Pandemic (H1N1) 2009 influenza. Br. J. Anaesth. 2010, 104, 128–142. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. 2009 H1N1 Pandemic. Centers for Disease Control and Prevention. Available online: https://www.cdc.gov/flu/pandemic-resources/2009-h1n1-pandemic.html (accessed on 11 June 2019).
  3. Krammer, F.; Smith, G.J.D.; Fouchier, R.A.M.; Peiris, M.; Kedzierska, K.; Doherty, P.C.; Palese, P.; Shaw, M.L.; Treanor, J.; Webster, R.G.; et al. Influenza. Nature Reviews. Dis. Primers 2018, 4, 3. [Google Scholar] [CrossRef] [PubMed]
  4. Jilani, T.N.; Jamil, R.T.; Siddiqui, A.H. H1N1 Influenza. In StatPearls; StatPearls Publishing: Treasure Island, FL, USA, 2021. [Google Scholar]
  5. Sriwilaijaroen, N.; Suzuki, Y. Molecular basis of the structure and function of H1 hemagglutinin of influenza virus. Proc. Jpn. Acad. Ser. B 2012, 88, 226–249. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Ravina, R.; Dalal, A.; Mohan, H.; Prasad, M.; Pundir, C. Detection methods for influenza A H1N1 virus with special reference to biosensors: A review. Biosci. Rep. 2020, 40, BSR20193852. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Antibodies Use in Biosensors. Available online: News-Medical.Net (accessed on 20 January 2021).
  8. Sharma, S.; Byrne, H.; O’Kennedy, R.J. Antibodies and antibody-derived analytical biosensors. Essays Biochem. 2016, 60, 9–18. [Google Scholar] [PubMed]
  9. Chambers, J.P.; Arulanandam, B.P.; Matta, L.L.; Weis, A.; Valdes, J.J. Biosensor recognition elements. Curr. Issues Mol. Biol. 2008, 10, 1–12. [Google Scholar] [PubMed]
  10. Wang, Y.C.; Cokeliler, D.; Gunasekaran, S. Reduced graphene oxide/carbon nanotube/gold nanopar-ticles nanocomposite functionalized screen-printed electrode for sensitive electrochemical detection of endocrine disruptor bisphenol A. Electroanalysis 2015, 27, 2527–2536. [Google Scholar] [CrossRef]
  11. Valerio, E.; Abrantes, L.M.; Viana, A.S. 4-Aminothiophenol Self-Assembled Monolayer for the De-velopment of a DNA Biosensor Aiming the Detection of Cylindrospermopsin Producing Cyanobacteria. Electro-Anal. Int. J. Devoted Fundam. Pract. Asp. Electroanal. 2008, 20, 2467–2474. [Google Scholar]
  12. Rezki, M.; Septiani, N.L.W.; Iqbal, M.; Harimurti, S.; Sambegoro, P.; Adhika, D.R.; Yuliarto, B. Amine-functionalized Cu-MOF Nanospheres towards Label-free Hepatitis B Surface Antigen Electrochemical Immunosensors. J. Mater. Chem. B 2021, 9, 5711–5721. [Google Scholar] [CrossRef] [PubMed]
  13. Sandwich ELISA Protocol|Sino Biological. (n.d.) Available online: https://www.sinobiological.com/category/sandwich-elisa-protocol (accessed on 13 June 2021).
  14. Damiati, S.; Haslam, C.; Sopstad, S.; Peacock, M.; Whitley, T.; Davey, P.; Awan, S. Sensitivity Comparison of Macro- and Micro-Electrochemical Biosensors for Human Chorionic Gonadotropin (hCG) Biomarker Detection. IEEE Access 2019, 7, 94048–94058. [Google Scholar] [CrossRef]
Figure 1. Cyclic voltammogram of CSPE, AuNP-CSPE and NH2-NP-CSPE in the presence of [Fe(CN)6]3-/4- obtained at a scan rate of 100 mV/s.
Figure 1. Cyclic voltammogram of CSPE, AuNP-CSPE and NH2-NP-CSPE in the presence of [Fe(CN)6]3-/4- obtained at a scan rate of 100 mV/s.
Chemproc 05 00080 g001
Figure 2. Cyclic voltammogram of modified AuNP-CSPEs using different electrodeposition times; the experiment was conducted in the presence of [Fe(CN)6]3-/4- at a scan rate of 100 mV/s.
Figure 2. Cyclic voltammogram of modified AuNP-CSPEs using different electrodeposition times; the experiment was conducted in the presence of [Fe(CN)6]3-/4- at a scan rate of 100 mV/s.
Chemproc 05 00080 g002
Figure 3. Nyquist plot of CSPE (A) and NH2-AuNP-CSPE (B) using the frequency range of 5.0 mHz to 50 kHz.
Figure 3. Nyquist plot of CSPE (A) and NH2-AuNP-CSPE (B) using the frequency range of 5.0 mHz to 50 kHz.
Chemproc 05 00080 g003
Figure 4. Fitting of CSPE to equivalent circuit for a simple electron transfer (A) and fitting of the NH2-AuNP-CSPE Randles equivalent circuit (B).
Figure 4. Fitting of CSPE to equivalent circuit for a simple electron transfer (A) and fitting of the NH2-AuNP-CSPE Randles equivalent circuit (B).
Chemproc 05 00080 g004
Figure 5. Cyclic voltammogram (A) and differential pulse voltammogram (B) for NH2-AuNP-CSPE as a function of the [Fe(CN)6]3-/4- concentration.
Figure 5. Cyclic voltammogram (A) and differential pulse voltammogram (B) for NH2-AuNP-CSPE as a function of the [Fe(CN)6]3-/4- concentration.
Chemproc 05 00080 g005
Figure 6. Indirect sandwich ELISA results using 1:500 dilution of mAb, 1:1000 dilution of pAb and different H1 concentrations as shown in the x axis; the y axis shows the emission measured after the addition of the secondary antibody. Experiments were conducted twice with replicates of 2–6.
Figure 6. Indirect sandwich ELISA results using 1:500 dilution of mAb, 1:1000 dilution of pAb and different H1 concentrations as shown in the x axis; the y axis shows the emission measured after the addition of the secondary antibody. Experiments were conducted twice with replicates of 2–6.
Chemproc 05 00080 g006
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Torres-Méndez, C.; Ellamathy, J.; Mascarenhas, M.I.; Liu, Y.; Gkountana, G.-V.; Kühne, P.; Sebastián, J.; Jovanovic, I.; Bern, D.; Nandi, S.; et al. Developing an Electrochemical Biosensor for the Detection of Hemagglutinin Protein of Influenza A Virus Subtype H1N1 in Artificial Saliva. Chem. Proc. 2021, 5, 80. https://doi.org/10.3390/CSAC2021-10477

AMA Style

Torres-Méndez C, Ellamathy J, Mascarenhas MI, Liu Y, Gkountana G-V, Kühne P, Sebastián J, Jovanovic I, Bern D, Nandi S, et al. Developing an Electrochemical Biosensor for the Detection of Hemagglutinin Protein of Influenza A Virus Subtype H1N1 in Artificial Saliva. Chemistry Proceedings. 2021; 5(1):80. https://doi.org/10.3390/CSAC2021-10477

Chicago/Turabian Style

Torres-Méndez, Carlos, Jayendra Ellamathy, Maria Ines Mascarenhas, Yifan Liu, Georgia-Vasiliki Gkountana, Patrizia Kühne, Javier Sebastián, Ivana Jovanovic, David Bern, Sharmilee Nandi, and et al. 2021. "Developing an Electrochemical Biosensor for the Detection of Hemagglutinin Protein of Influenza A Virus Subtype H1N1 in Artificial Saliva" Chemistry Proceedings 5, no. 1: 80. https://doi.org/10.3390/CSAC2021-10477

Article Metrics

Back to TopTop